These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19478791)

  • 1. Factors associated with compliance, discontinuation and switching of calcium channel blockers in 20,156 Chinese patients.
    Wong MC; Jiang JY; Griffiths SM
    Am J Hypertens; 2009 Aug; 22(8):904-10. PubMed ID: 19478791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions.
    Wong MC; Jiang JY; Lam AT; Fung H; Griffiths S; Mercer SW
    J Hum Hypertens; 2008 Oct; 22(10):714-6. PubMed ID: 18650836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy.
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):587-93. PubMed ID: 16586465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: a cohort study.
    Wong MC; Jiang JY; Griffiths SM
    Clin Ther; 2009 Oct; 31(10):2170-7; discussion 2150-1. PubMed ID: 19922888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive persistence and drug class.
    Marentette MA; Gerth WC; Billings DK; Zarnke KB
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term discontinuation patterns of commonly prescribed antihypertensive drugs among a Chinese population: cohort study.
    Wong MC
    J Hum Hypertens; 2008 Jun; 22(6):435-7. PubMed ID: 18322547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use and adverse reactions of antihypertensive drugs in Spain. Part I of the RAAE Study.
    Aranda P; Tamargo J; Aranda FJ; Luque M; López-Garcia-Franco A
    Blood Press Suppl; 1997; 1():11-6. PubMed ID: 9285102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence with treatment in newly treated middle-aged patients with essential hypertension.
    Perreault S; Lamarre D; Blais L; Dragomir A; Berbiche D; Lalonde L; Laurier C; St-Maurice F; Collin J
    Ann Pharmacother; 2005 Sep; 39(9):1401-8. PubMed ID: 16076920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with antihypertensive drug compliance in 83,884 Chinese patients: a cohort study.
    Wong MC; Jiang JY; Griffiths SM
    J Epidemiol Community Health; 2010 Oct; 64(10):895-901. PubMed ID: 20693495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quality of life and antihypertensive therapy].
    Vajó Z; Székács B
    Orv Hetil; 1993 Nov; 134(45):2477-9. PubMed ID: 7902554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of elderly hypertension with Ca channel blockers].
    Saito F; Kushiro T
    Clin Calcium; 2005 Oct; 15(10):1717-25. PubMed ID: 16199919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating hypertension. Are the right drugs given to the right patients?
    Beaulieu MD; Dufresne L; LeBlanc D
    Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the compliance of antihypertensive drugs in patients with hypertension].
    Guo H; He H; Jiang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Dec; 22(6):418-20. PubMed ID: 11851054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching of antihypertensive drugs among 93,286 Chinese patients: a cohort study.
    Wong MC; Jiang JY; Griffiths SM
    J Hum Hypertens; 2010 Oct; 24(10):669-77. PubMed ID: 20054349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockers and myocardial infarction: a case--control study in a Japanese hospital.
    Ohyama Y; Funao K; Kawabe E; Hayashi D; Yamazaki T; Iga T; Koide D; Ohe K; Kubota K
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):487-92. PubMed ID: 12426933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of use of immediate-release formulations of calcium channel blockers as antihypertensive monotherapy by primary care physicians: multicentric study from Bahrain.
    Sequeira RP; Jassim Al Khaja KA; Mathur VS
    J Postgrad Med; 2002; 48(3):172-5. PubMed ID: 12432188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy.
    Corrao G; Zambon A; Parodi A; Poluzzi E; Baldi I; Merlino L; Cesana G; Mancia G
    J Hypertens; 2008 Apr; 26(4):819-24. PubMed ID: 18327094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockers in treatment of hypertension.
    Muntwyler J; Follath F
    Prog Cardiovasc Dis; 2001; 44(3):207-16. PubMed ID: 11727278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using medication history to measure confounding by indication in assessing calcium channel blockers and other antihypertensive therapy.
    Leader S; Mallick R; Roht L
    J Hum Hypertens; 2001 Mar; 15(3):153-9. PubMed ID: 11317198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term persistence with antihypertensive drugs in new patients.
    Degli Esposti E; Sturani A; Di Martino M; Falasca P; Novi MV; Baio G; Buda S; Volpe M
    J Hum Hypertens; 2002 Jun; 16(6):439-44. PubMed ID: 12037702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.